Refining the value of secretory phospholipase A 2 as a predictor of acute chest syndrome in sickle cell disease: Results of a feasibility study (PROACTIVE)

British Journal of Haematology

Volumn 157, Issue 5, 2012, Pages 627-636

  Styles, Lori ^a   Wager, Carrie G ^b   Labotka, Richard J ^c   Smith Whitley, Kim ^d   Thompson, Alexis A ^e   Lane, Peter A ^f   McMahon, Lillian E C ^g   Miller, Robin ^h   Roseff, Susan D ⁱ   Iyer, Rathi V ^j   Hsu, Lewis L ^k   Castro, Oswaldo L ^l   Ataga, Kenneth I ^m   Onyekwere, Onyinye ^l   Okam, Maureen ⁿ   Bellevue, Rita ^o   Miller, Scott T ^b,p  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e CHILDREN'S MEMORIAL HOSPITAL   (United States)

^f CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^g BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^h NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

ⁱ VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^j UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^k CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^l HOWARD UNIVERSITY   (United States)

^m UNIVERSITY OF NORTH CAROLINA   (United States)

ⁿ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^o NEW YORK METHODIST HOSPITAL   (United States)

^p SUNY DOWNSTATE MEDICAL CENTER   (United States)

more..

Author keywords

Acute chest syndrome; Pulmonary fat embolism; SPLA2; Transfusion; Vaso occlusive episode

Indexed keywords

HEMOGLOBIN; SECRETORY PHOSPHOLIPASE A2;

ACUTE CHEST SYNDROME; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD TRANSFUSION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME BLOOD LEVEL; FEASIBILITY STUDY; FEMALE; FEVER; FLUID INTAKE; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SICKLE CELL ANEMIA; THORAX PAIN;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; PHOSPHOLIPASES A2, SECRETORY; PROGNOSIS; YOUNG ADULT;

EID: 84860839262     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09105.x     Document Type: Article

References (50)

1. Abboud, M.R., Taylor, E.C., Habib, D., Dantzler-Johnson, T., Jackson, S.M., Xu, F., Laver, J. & Ballas, S.K. (2000) Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. British Journal of Haematology, 111, 482-490.
2. Afenyi-Annan, A., Kail, M., Combs, M.R., Orringer, E.P., Ashley-Koch, A. & Telen, M.J. (2008) Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. Transfusion, 48, 917-924.
3. Anderson, B.O., Moore, E.E. & Banerjee, A. (1994) Phospholipase A2 regulates critical inflammatory mediators of multiple organ failure. Journal of Surgical Research, 56, 199-205.
4. Ardiles, T. & Dark, D. (2007) Pulmonary complications of sickle cell disease in adults. Missouri Medicine, 104, 250-254.
5. Ballas, S.K., Files, B., Luchtman-Jones, L., Benjamin, L., Swerdlow, P., Hilliard, L., Coates, T., Abboud, M., Wojtowicz-Praga, S., Kuypers, F.A. & Michael Grindel, J. (2006) Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin, 30, 165-170.
6. Baur, M., Schmid, T.-O. & Landauer, B. (1989) Role of phospholipase A in multiorgan failure with special reference to ARDS and acute renal failure (ARF). Klinische Wochenschrift, 67, 196.
7. Bellet, P.S., Kalinyak, K.A., Shukla, R., Gelfand, M.J. & Rucknagel, D.L. (1995) Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. New England Journal of Medicine, 333, 699-703.
8. Breiman, L. (1984) Classification and regression trees. Wadsworth International Group, Belmont, CA, USA.
9. Buchanan, I.D., Woodward, M. & Reed, G.W. (2005) Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Pediatric Blood & Cancer, 45, 716-724.
10. Castro, O., Brambilla, D.J., Thorington, B., Reindorf, C.A., Scott, R.B., Gillette, P., Vera, J.C. & Levy, P.S. (1994) The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood, 84, 643-649.
11. Emre, U., Miller, S.T., Gutierez, M., Steiner, P., Rao, S.P. & Rao, M. (1995) Effect of transfusion in acute chest syndrome of sickle cell disease. Journal of Pediatrics, 127, 901-904.
12. Gelfand, M.J., Daya, S.A., Rucknagel, D.L., Kalinyak, K.A. & Paltiel, H.J. (1993) Simultaneous occurrence of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome. Journal of Nuclear Medicine, 34, 614-618.
13. Girard, W. (1979) Case report: postoperative pulmonary edema and sickle cell crisis. Clinical Notes Respiratory Disease, 17, 13-14.
14. Green, J.-A., Smith, G.M., Buchta, R., Lee, R. & Ho, K.Y. (1991) Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Inflammation, 15, 335.
15. Hadley, T.J. & Peiper, S.C. (1997) From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood, 89, 3077-3091.
16. Hankins, J., Jeng, M., Harris, S., Li, C.S., Liu, T. & Wang, W. (2005) Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. Journal of Pediatric Hematology/oncology, 27, 158-161.
17. Haynes, Jr, J. & Allison, R.C. (1986) Pulmonary edema. Complication in the management of sickle cell pain crisis. American Journal of Medicine, 80, 833-840.
18. Henderson, Jr, W.R. (1987) Eicosanoids and lung inflammation. American Review Respiatory Disease, 135, 1176-1185.
19. Johnson, C.S. & Verdegem, T.D. (1988) Pulmonary complications of sickle cell disease. Seminars in Respiratory Medicine, 9, 287-296.
20. Koenig, W., Vossen, C.Y., Mallat, Z., Brenner, H., Benessiano, J. & Rothenbacher, D. (2009) Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. European Heart Journal, 30, 2742-2748.
21. Koike, K., Yamamoto, Y., Hori, Y. & Ono, T. (2000) Group IIA phospholipase A2 mediates lung injury in intestinal ischemia-reperfusion. Annals of Surgery, 232, 90-97.
22. Kolquist, K.A., Vnencak-Jones, C.L., Swift, L., Page, D.L., Johnson, J.E. & Denison, M.R. (1996) Fatal fat embolism syndrome in a child with undiagnosed hemoglobin S-beta+ thalassemia: a complication of acute parvovirus B19 infection. Pediatric Pathology and Laboratory Medicine, 16, 71-82.
23. Kuypers, F. & Styles, L.A. (2004) The role of secretory phospholipase A2 in acute chest syndrome. Cellular and Molecular Biology, 50, 87-94.
24. Kuypers, F.A., Larkin, S.A., Styles, L. & de Jong, K. (1999) Secretory phospholipase A2 induced endothelial damage: a possible role in acute chest syndrome. Blood, 94, 420a.
25. Lewis, R.A., Austen, K.F. & Soberman, R.J. (1990) Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. New England Journal of Medicine, 323, 645-655.
26. Liem, R.I., O'Gorman, M.R. & Brown, D.L. (2004) Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome. American Journal of Hematology, 76, 19-25.
27. Mallouh, A.A. & Asha, M. (1988) Beneficial effect of blood transfusion in children with sickle cell chest syndrome. American Journal of Diseases of Children, 142, 178-182.
28. Miller, S.T., Wright, E., Abboud, M., Berman, B., Files, B., Scher, C.D., Styles, L. & Adams, R.J. (2001) Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. Journal of Pediatrics, 139, 785-789.
29. Miller, S.T., Kim, H.Y., Weiner, D., Wager, C.G., Gallagher, D., Styles, L. & Dampier, C.D. (2012) Inpatient management of sickle cell pain: a 'snapshot' of current practice. American Journal of Hematology, 87, 333-336.
30. Naprawa, J.T., Bonsu, B.K., Goodman, D.G. & Ranalli, M.A. (2005) Serum biomarkers for identifying acute chest syndrome among patients who have sickle cell disease and present to the emergency department. Pediatrics, 116, e420-e425.
31. Needleman, J.P., Benjamin, L.J., Sykes, J.A. & Aldrich, T.K. (2002) Breathing patterns during vaso-occlusive crisis of sickle cell disease. Chest, 122, 43-46.
32. Nevalainen, T. (1993) Serum phospholipase A2 in inflammatory diseases. Clinical Chemistry, 39, 2453.
33. Pfeilschifter, J., Pignat, W. & Vosbeck, K. (1989) Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells. Biochemical and Biophysical Research Communications, 159, 385.
34. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639-1644.
35. Powars, D., Weidman, J.A., Odom-Maryon, T., Niland, J.C. & Johnson, C. (1988) Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine, 67, 66-76.
36. Rucknagel, D.L. (2001) The role of rib infarcts in the acute chest syndrome of sickle cell diseases. Pediatric Pathology Molecular Medicine, 20, 137-154.
37. Sakhalkar, V.S., Rao, S.P., Weedon, J. & Miller, S.T. (2004) Elevated plasma sVCAM-1 levels in children with sickle cell disease: impact of chronic transfusion therapy. American Journal of Hematology, 76, 57-60.
38. Smith, G.M., Ward, R.L., McGuigan, L., Rajkovic, I.A. & Scott, K.F. (1992) Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. British Journal of Rheumatology, 31, 175-178.
39. Sprinkle, R.H., Cole, T., Smith, S. & Buchanan, G.R. (1986) Acute chest syndrome in children with sickle cell disease. American Journal of Pediatric Hematology/Oncology, 8, 105-110.
40. Strobl, C., Boulesteix, A.L., Kneib, T., Augustin, T. & Zeileis, A. (2008) Conditional variable importance for random forests. BMC Bioinformatics, 9, 307.
41. Stuart, M.J. & Setty, B.N. (1999) Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood, 94, 1555-1560.
42. Styles, L.A., Schalkwijk, C.G., Aarsman, A.J., Vichinsky, E.P., Lubin, B.H. & Kuypers, F.A. (1996) Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood, 87, 2573-2578.
43. Styles, L.A., Aarsman, A.J., Vichinsky, E.P. & Kuypers, F.A. (2000) Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood, 96, 3276-3278.
44. Styles, L.A., Abboud, M., Larkin, S., Lo, M. & Kuypers, F.A. (2007) Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. British Journal of Haematology, 136, 343-344.
45. Vichinsky, E. (1991) Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Seminars in Hematology, 28, 220.
46. Vichinsky, E. (1997) Mortality of acute chest syndrome in sickle cell disease. Blood, 90, 264a.
47. Vichinsky, E.P., Williams, R., Das, M., Earles, A.N., Lewis, N., Adler, A. & McQuitty, J. (1994) Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood, 83, 3107-3112.
48. Vichinsky, E.P., Styles, L.A., Colangelo, L.H., Wright, E.C., Castro, O. & Nickerson, B. (1997) Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative study of sickle cell disease. Blood, 89, 1787-1792.
49. Vichinsky, E.P., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C. & Manci, E.A. (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine, 342, 1855-1865.
50. Weil, J.V., Castro, O., Malik, A.B., Rodgers, G., Bonds, D.R. & Jacobs, T.P. (1993) Pathogenesis of lung disease in sickle hemoglobinopathies. American Review of Respiratory Disease, 148, 249-256.